FDA chief struggles to explain slow response on baby formula

Automatic TRANSCRIPT

Over months of delays investigating problems at the nation's largest baby formula plant that prompted an ongoing shortage FDA commissioner Robert califf told Congress the coronavirus slowed down efforts to investigate problems at the abbot plant We knew that ceasing plant operations would create supply problems but we had no choice given the insanitary conditions The ranking Republican on the committee Virginia's Morgan Griffith quickly zeroed in on the slow response Why did it take an onslaught of national media attention for the Biden administration to act with the sense of urgency that is required to adequately address an infant formula shortage Formula had to be airlifted from Europe to help ease the shortage Abbott and the FDA have reached an agreement to reopen the plant next

Coming up next